RETINOID INDUCTION OF HAIRLESS MOUSE EPIDERMAL HYPERPLASIA IS RAR RECEPTOR-SELECTIVE

被引：0
|
作者：
THACHER, S [1 ]
ATHANIKAR, J [1 ]
KOPPER, S [1 ]
CHANDRARATNA, R [1 ]
机构：
[1] ALLERGAN PHARMACEUT INC,RETINOID RES,IRVINE,CA 92715
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1994年 / 102卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：554 / 554
页数：1
相关论文
共 50 条
  • [41] Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin binding-EGF and amphiregulin in human skin in vivo
    Rittie, L
    Varani, J
    Fisher, GJ
    Voorhees, JJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A49 - A49
  • [42] The structural basis for the specificity of retinoid-X receptor-selective agonists: New insights into the role of helix H12
    Love, JD
    Gooch, JT
    Benko, S
    Li, C
    Nagy, L
    Chatterjee, VKK
    Evans, RM
    Schwabe, JWR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) : 11385 - 11391
  • [43] Beyond tamoxifen: The retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma
    Bischoff, ED
    Gottardis, MM
    Moon, TE
    Heyman, RA
    Lamph, WW
    CANCER RESEARCH, 1998, 58 (03) : 479 - 484
  • [44] Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma
    Yen, WC
    Prudente, RY
    Lamph, WW
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (02) : 141 - 148
  • [45] Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer (vol 12, pg 7877, 2019)
    Shen, Danyang
    Wang, Huan
    Zheng, Qiming
    Cheng, Sheng
    Xu, Liwei
    Wang, Mingchao
    Li, Gonghui
    Xia, Liqun
    ONCOTARGETS AND THERAPY, 2019, 12 : 8807 - 8807
  • [46] The effect on nasopharyngeal carcinoma by ZD1839, an epidermal growth factor receptor-selective tyrosine kinase inhibitor
    Guan, Zhong-Zhen
    Wang, Shu-Sen
    ANNALS OF ONCOLOGY, 2004, 15 : 141 - 141
  • [47] Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma
    Wan-ching Yen
    Rene Y. Prudente
    William W. Lamph
    Breast Cancer Research and Treatment, 2004, 88 : 141 - 148
  • [48] Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients
    Evans, Rebecca
    Kimura, Haruhide
    Alexander, Robert
    Davies, Ceri H.
    Faessel, Helene
    Hartman, Deborah S.
    Ishikawa, Takashi
    Ratti, Emiliangelo
    Shimizu, Kohei
    Suzuki, Motohisa
    Tanaka, Shinichiro
    Yukitake, Hiroshi
    Dauvilliers, Yves
    Mignot, Emmanuel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (35)
  • [49] Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells
    Sun, SY
    Yue, P
    Dawson, MI
    Shroot, B
    Michel, S
    Lamph, WW
    Heyman, RA
    Teng, M
    Chandraratna, RAS
    Shudo, K
    Hong, WK
    Lotan, R
    CANCER RESEARCH, 1997, 57 (21) : 4931 - 4939
  • [50] Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids
    Wu, Q
    Dawson, MI
    Zheng, Y
    Hobbs, PD
    Agadir, A
    Jong, L
    Li, Y
    Liu, R
    Lin, BZ
    Zhang, XK
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) : 6598 - 6608
12345